A possible trial could measure vitamin D in DS subjects and follow them over time on vitamin D supplements (if vitamin D is low) to determine the leptin/adiponectin ratio, any change in the ratios and the occurrence of leukemia, solid tumors, and Alzheimer’s disease. The gene discussed is ADIPOQ; the disease is Alzheimer disease.